FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014389626> ?p ?o ?g. }

• W2014389626 endingPage "90" @default.
• W2014389626 startingPage "82" @default.
• W2014389626 abstract "Estrogen replacement therapy has been correlated with an increased risk of developing hormone-dependent cancers. 4-Hydroxyequilenin (4-OHEN) is a catechol metabolite of equilenin and equilin which are components of the estrogen replacement formulation marketed under the name of Premarin (Wyeth-Ayerst). Previously, we showed that 4-OHEN autoxidizes to potent cytotoxic quinoids which can consume reducing equivalents and molecular oxygen, and cause a variety of DNA lesions, including formation of bulky stable adducts, apurinic sites, and oxidation of the phosphate-sugar backbone and purine/pyrimidine bases [Bolton, J. L., Pisha, E., Zhang, F., and Qiu, S. (1998) Chem. Res. Toxicol. 11, 1113-1127]. All of these deleterious effects could contribute to the cytotoxic/genotoxic effects of equine estrogens in vivo. In the study presented here, we studied the oxidative and carcinogenic potential of 4-OHEN and the catechol metabolite of the endogenous estrogen, 4-hydroxyestrone (4-OHE), in the JB6 clone 41 5a and C3H 10T(1/2) murine fibroblast cells. The relative ability of 4-OHEN and 4-OHE to induce oxidative stress was measured in these cells by oxidative cleavage of 2',7'-dichlorodiacylfluorosceindiacetate to dichlorofluoroscein. 4-OHEN (1 microM) displayed an increase in the level of reactive oxygen species comparable to that observed with 100 microM H(2)O(2). In contrast, 4-OHE demonstrated antioxidant capabilities in the 5-50 microM range. With both cell lines, we assessed single-strand DNA cleavage using the comet assay and the formation of oxidized DNA bases, such as 8-oxodeoxyguanosine, utilizing the Trevigen Fpg comet assay. 4-OHEN caused single-strand breaks and oxidized bases in a dose-dependent manner in both cell lines, whereas 4-OHE did not induce DNA damage. Since oxidative stress has been implicated in cellular transformation, we used the JB6 clone 41 5a anchorage independence assay to ascertain the relative ability of 4-OHEN and 4-OHE to act as tumor promoters. 4-OHEN caused a slight but significant increase in the extent of cellular transformation at the 100 nM dose; however, in the presence of NADH, which catalyzes redox cycling of 4-OHEN, the transformation ability of 4-OHEN was dramatically increased. 4-OHE did not induce transformation of the JB6 clone 41 5a in the 0.1-10 microM range. The initiation, promotion, and complete carcinogenic transformation potentials of both metabolites were measured in the C3H 10T(1/2) cells. 4-OHEN demonstrated activity in all stages of transformation at doses of 10 nM to 1 microM, whereas 4-OHE only demonstrated promotional capabilities at the 10 microM dose. These data suggest that oxidative stress could be partially responsible for the carcinogenic effects caused by 4-OHEN and that 4-OHEN is a more potent transforming agent than 4-OHE in vitro." @default.
• W2014389626 created "2016-06-24" @default.
• W2014389626 creator A5007485964 @default.
• W2014389626 creator A5011983627 @default.
• W2014389626 creator A5080984608 @default.
• W2014389626 creator A5088160011 @default.
• W2014389626 date "2000-12-13" @default.
• W2014389626 modified "2023-09-25" @default.
• W2014389626 title "Evidence That a Metabolite of Equine Estrogens, 4-Hydroxyequilenin, Induces Cellular Transformation in Vitro" @default.
• W2014389626 cites W1969190950 @default.
• W2014389626 cites W1987250101 @default.
• W2014389626 cites W1987441155 @default.
• W2014389626 cites W1995698844 @default.
• W2014389626 cites W2042784347 @default.
• W2014389626 cites W2046983903 @default.
• W2014389626 cites W2073189025 @default.
• W2014389626 cites W2075987834 @default.
• W2014389626 cites W2082176660 @default.
• W2014389626 cites W2323923429 @default.
• W2014389626 cites W2607238143 @default.
• W2014389626 cites W4243574300 @default.
• W2014389626 doi "https://doi.org/10.1021/tx000168y" @default.
• W2014389626 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11170511" @default.
• W2014389626 hasPublicationYear "2000" @default.
• W2014389626 type Work @default.
• W2014389626 sameAs 2014389626 @default.
• W2014389626 citedByCount "44" @default.
• W2014389626 countsByYear W20143896262012 @default.
• W2014389626 countsByYear W20143896262019 @default.
• W2014389626 crossrefType "journal-article" @default.
• W2014389626 hasAuthorship W2014389626A5007485964 @default.
• W2014389626 hasAuthorship W2014389626A5011983627 @default.
• W2014389626 hasAuthorship W2014389626A5080984608 @default.
• W2014389626 hasAuthorship W2014389626A5088160011 @default.
• W2014389626 hasConcept C134018914 @default.
• W2014389626 hasConcept C143425029 @default.
• W2014389626 hasConcept C153911025 @default.
• W2014389626 hasConcept C185592680 @default.
• W2014389626 hasConcept C2776151105 @default.
• W2014389626 hasConcept C2777164284 @default.
• W2014389626 hasConcept C2777477808 @default.
• W2014389626 hasConcept C552990157 @default.
• W2014389626 hasConcept C55493867 @default.
• W2014389626 hasConcept C86803240 @default.
• W2014389626 hasConceptScore W2014389626C134018914 @default.
• W2014389626 hasConceptScore W2014389626C143425029 @default.
• W2014389626 hasConceptScore W2014389626C153911025 @default.
• W2014389626 hasConceptScore W2014389626C185592680 @default.
• W2014389626 hasConceptScore W2014389626C2776151105 @default.
• W2014389626 hasConceptScore W2014389626C2777164284 @default.
• W2014389626 hasConceptScore W2014389626C2777477808 @default.
• W2014389626 hasConceptScore W2014389626C552990157 @default.
• W2014389626 hasConceptScore W2014389626C55493867 @default.
• W2014389626 hasConceptScore W2014389626C86803240 @default.
• W2014389626 hasIssue "1" @default.
• W2014389626 hasLocation W20143896261 @default.
• W2014389626 hasLocation W20143896262 @default.
• W2014389626 hasOpenAccess W2014389626 @default.
• W2014389626 hasPrimaryLocation W20143896261 @default.
• W2014389626 hasRelatedWork W1964175376 @default.
• W2014389626 hasRelatedWork W1970203623 @default.
• W2014389626 hasRelatedWork W2052493351 @default.
• W2014389626 hasRelatedWork W2164902408 @default.
• W2014389626 hasRelatedWork W2328839710 @default.
• W2014389626 hasRelatedWork W3111852869 @default.
• W2014389626 hasRelatedWork W3176278069 @default.
• W2014389626 hasRelatedWork W4311130491 @default.
• W2014389626 hasRelatedWork W4380291273 @default.
• W2014389626 hasRelatedWork W2183235121 @default.
• W2014389626 hasVolume "14" @default.
• W2014389626 isParatext "false" @default.
• W2014389626 isRetracted "false" @default.
• W2014389626 magId "2014389626" @default.
• W2014389626 workType "article" @default.